Leurgans S - Search Results

1

The Montreal Cognitive Assessment as a screening tool for cognitive dysfunction in Huntington's disease.

Videnovic A, Bernard B, Fan W, Jaglin J, Leurgans S, Shannon KM. Videnovic A, et al. Among authors: leurgans s. Mov Disord. 2010 Feb 15;25(3):401-4. doi: 10.1002/mds.22748. Mov Disord. 2010. PMID: 20108371

2

"On" freezing in Parkinson's disease: resistance to visual cue walking devices.

Kompoliti K, Goetz CG, Leurgans S, Morrissey M, Siegel IM. Kompoliti K, et al. Among authors: leurgans s. Mov Disord. 2000 Mar;15(2):309-12. doi: 10.1002/1531-8257(200003)15:2<309::aid-mds1016>3.0.co;2-p. Mov Disord. 2000. PMID: 10752582 Clinical Trial.

3

Menstrual-related changes in motoric function in women with Parkinson's disease.

Kompoliti K, Comella CL, Jaglin JA, Leurgans S, Raman R, Goetz CG. Kompoliti K, et al. Among authors: leurgans s. Neurology. 2000 Nov 28;55(10):1572-5. doi: 10.1212/wnl.55.10.1572. Neurology. 2000. PMID: 11094119

4

Cognitive and motor function in patients with Parkinson's disease with and without depression.

Cubo E, Bernard B, Leurgans S, Raman R. Cubo E, et al. Among authors: leurgans s. Clin Neuropharmacol. 2000 Nov-Dec;23(6):331-4. doi: 10.1097/00002826-200011000-00006. Clin Neuropharmacol. 2000. PMID: 11575867 Clinical Trial.

5

Goetz CG, Wuu J, Curgian L, Leurgans S. Goetz CG, et al. Among authors: leurgans s. Mov Disord. 2006 Feb;21(2):267-70. doi: 10.1002/mds.20701. Mov Disord. 2006. PMID: 16161144

6

Comparison of botulinum toxin serotypes A and B for the treatment of cervical dystonia.

Comella CL, Jankovic J, Shannon KM, Tsui J, Swenson M, Leurgans S, Fan W; Dystonia Study Group. Comella CL, et al. Among authors: leurgans s. Neurology. 2005 Nov 8;65(9):1423-9. doi: 10.1212/01.wnl.0000183055.81056.5c. Neurology. 2005. PMID: 16275831 Clinical Trial.

7

Single-blind clinical trial of psychotherapy for treatment of psychogenic movement disorders.

Hinson VK, Weinstein S, Bernard B, Leurgans SE, Goetz CG. Hinson VK, et al. Among authors: leurgans se. Parkinsonism Relat Disord. 2006 Apr;12(3):177-80. doi: 10.1016/j.parkreldis.2005.10.006. Epub 2005 Dec 20. Parkinsonism Relat Disord. 2006. PMID: 16364676 Clinical Trial.

8

The malignant course of "benign hallucinations" in Parkinson disease.

Goetz CG, Fan W, Leurgans S, Bernard B, Stebbins GT. Goetz CG, et al. Among authors: leurgans s. Arch Neurol. 2006 May;63(5):713-6. doi: 10.1001/archneur.63.5.713. Arch Neurol. 2006. PMID: 16682540

9

Association of daytime napping and Parkinsonian signs in Alzheimer's disease.

Park M, Comella CL, Leurgans SE, Fan W, Wilson RS, Bennett DA. Park M, et al. Among authors: leurgans se. Sleep Med. 2006 Dec;7(8):614-8. doi: 10.1016/j.sleep.2006.02.006. Epub 2006 Oct 4. Sleep Med. 2006. PMID: 17023213

10

Effect of donepezil on motor and cognitive function in Huntington disease.

Cubo E, Shannon KM, Tracy D, Jaglin JA, Bernard BA, Wuu J, Leurgans SE. Cubo E, et al. Among authors: leurgans se. Neurology. 2006 Oct 10;67(7):1268-71. doi: 10.1212/01.wnl.0000238106.10423.00. Neurology. 2006. PMID: 17030764 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

338 results

Search Page

Filters